EC expanded Merckメs VAXNEUVANCEル indication to include infants, children and adolescents
On Oct. 24, 2022, Merck announced that the European Commission had approved an expanded indication for VAXNEUVANCEル (Pneumococcal…
On Oct. 24, 2022, Merck announced that the European Commission had approved an expanded indication for VAXNEUVANCEル (Pneumococcal…
On Nov. 16, 2021, an agreement was announced that enabled the European Union and European Economic Area countries…
On Aug. 11, 1918, the first influenza epidemic cases arrived in New York City with a Norwegian vessel…